Drugmaker Mallinckrodt on Oct. 10 won court approval for a bankruptcy plan that cuts $1 billion from what it must pay opioid crisis victims, cancels existing equity shares, and trims nearly $2 billion in other debt. The Ireland-based company reached …
from News Archives - Insurance Journal https://ift.tt/MujBVv6
via
IFTTT
No comments:
Post a Comment